166 related articles for article (PubMed ID: 8986534)
21. Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostate tissues.
Cohen DW; Simak R; Fair WR; Melamed J; Scher HI; Cordon-Cardo C
J Urol; 1994 Dec; 152(6 Pt 1):2120-4. PubMed ID: 7525998
[TBL] [Abstract][Full Text] [Related]
22. Expression of transforming growth factor-alpha, epidermal growth factor, and epidermal growth factor receptor in follicles of human ovarian tissue before and after cryopreservation.
Qu J; Nisolle M; Donnez J
Fertil Steril; 2000 Jul; 74(1):113-21. PubMed ID: 10899507
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
Rusch V; Baselga J; Cordon-Cardo C; Orazem J; Zaman M; Hoda S; McIntosh J; Kurie J; Dmitrovsky E
Cancer Res; 1993 May; 53(10 Suppl):2379-85. PubMed ID: 7683573
[TBL] [Abstract][Full Text] [Related]
24. Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro.
Morishige K; Kurachi H; Amemiya K; Fujita Y; Yamamoto T; Miyake A; Tanizawa O
Cancer Res; 1991 Oct; 51(19):5322-8. PubMed ID: 1717146
[TBL] [Abstract][Full Text] [Related]
25. S100P is a useful marker for differentiation of ovarian mucinous tumors.
Umezaki Y; Ito M; Nakashima M; Mihara Y; Naruke Y; Kurohama H; Yatsunami N; Yasuhi I
Eur J Gynaecol Oncol; 2015; 36(2):138-41. PubMed ID: 26050349
[TBL] [Abstract][Full Text] [Related]
26. Assessment of Her-1, Her-2, And Her-3 expression and Her-2 amplification in advanced stage ovarian carcinoma.
Lee CH; Huntsman DG; Cheang MC; Parker RL; Brown L; Hoskins P; Miller D; Gilks CB
Int J Gynecol Pathol; 2005 Apr; 24(2):147-52. PubMed ID: 15782071
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical studies on EGF family growth factors in normal and ulcerated human gastric mucosa.
Abe S; Sasano H; Katoh K; Ohara S; Arikawa T; Noguchi T; Asaki S; Yasui W; Tahara E; Nagura H; Toyota T
Dig Dis Sci; 1997 Jun; 42(6):1199-209. PubMed ID: 9201085
[TBL] [Abstract][Full Text] [Related]
28. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival.
Reinartz JJ; George E; Lindgren BR; Niehans GA
Hum Pathol; 1994 Oct; 25(10):1075-83. PubMed ID: 7927313
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor receptor and transforming growth factor alpha expression in human ovarian carcinomas.
Kohler M; Bauknecht T; Grimm M; Birmelin G; Kommoss F; Wagner E
Eur J Cancer; 1992; 28A(8-9):1432-7. PubMed ID: 1515265
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneous distribution of K-ras-mutated epithelia in mucinous ovarian tumors with special reference to histopathology.
Mandai M; Konishi I; Kuroda H; Komatsu T; Yamamoto S; Nanbu K; Matsushita K; Fukumoto M; Yamabe H; Mori T
Hum Pathol; 1998 Jan; 29(1):34-40. PubMed ID: 9445131
[TBL] [Abstract][Full Text] [Related]
31. Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.
Qi CF; Liscia DS; Normanno N; Merlo G; Johnson GR; Gullick WJ; Ciardiello F; Saeki T; Brandt R; Kim N
Br J Cancer; 1994 May; 69(5):903-10. PubMed ID: 8180021
[TBL] [Abstract][Full Text] [Related]
32. The epidermal growth factor family in pulmonary carcinoids: immunohistochemical evidence of growth-promoting circuits.
Battista P; Pizzicannella G; Vitullo P; Palmirotta R; Mariani-Costantini R
Mod Pathol; 1993 Mar; 6(2):162-6. PubMed ID: 8097879
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.
Wang DP; Konishi I; Koshiyama M; Nanbu Y; Iwai T; Nonogaki H; Mori T; Fujii S
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):393-400. PubMed ID: 1360720
[TBL] [Abstract][Full Text] [Related]
34. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
Ramalingam P
Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of p21WAF1/CIP1 and MDM2 characterizes serous borderline ovarian tumors.
Palazzo JP; Monzon F; Burke M; Hyslop T; Dunton C; Barusevicius A; Capuzzi D; Kovatich AJ
Hum Pathol; 2000 Jun; 31(6):698-704. PubMed ID: 10872663
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of epidermal growth factor-related proteins in human colorectal tumors.
Ciardiello F; Kim N; Saeki T; Dono R; Persico MG; Plowman GD; Garrigues J; Radke S; Todaro GJ; Salomon DS
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7792-6. PubMed ID: 1715580
[TBL] [Abstract][Full Text] [Related]
37. The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma.
Skirnisdóttir I; Sorbe B; Seidal T
Int J Gynecol Cancer; 2001; 11(2):119-29. PubMed ID: 11328410
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor alpha, amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomas.
D'Antonio A; Losito S; Pignata S; Grassi M; Perrone F; De Luca A; Tambaro R; Bianco C; Gullick WJ; Johnson GR; Iaffaioli VR; Salomon DS; Normanno N
Int J Oncol; 2002 Nov; 21(5):941-8. PubMed ID: 12370739
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors.
Tashiro Y; Yonezawa S; Kim YS; Sato E
Hum Pathol; 1994 Apr; 25(4):364-72. PubMed ID: 8163269
[TBL] [Abstract][Full Text] [Related]
40. Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues.
Panico L; D'Antonio A; Salvatore G; Mezza E; Tortora G; De Laurentiis M; De Placido S; Giordano T; Merino M; Salomon DS; Mullick WJ; Pettinato G; Schnitt SJ; Bianco AR; Ciardiello F
Int J Cancer; 1996 Jan; 65(1):51-6. PubMed ID: 8543395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
